Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
ekoscorp.com

See what CB Insights has to offer

Executives

5

Board of Directors

7

Ekos Board of Directors

7 Board of directors

Ekos has 7 board of directors, including Abhijeet Lele.

Name

Firm

Work History

Other Seats

Abhijeet Lele

Abhijeet joined Investor Growth Capital as a Managing Director in April 2009. He is based in IGC’s New York office and focuses on investments in pharmaceutical and medical device companies. Before joining IGC, Abhijeet spent 10 years as a Managing Member of EGS Healthcare Capital Partners, a venture capital firm focusing on private and public investments in biotechnology, specialty pharmaceutical and medical device companies. Prior to EGS, Abhijeet was with the New York offices of McKinsey & Co., where he primarily served medical device, pharmaceutical and health insurance clients. He previously held operating positions with Lederle Laboratories, Progenics Pharmaceuticals and Clontech Laboratories. Abhijeet received an M.B.A. from Cornell University and an M.A. from Cambridge University, where he studied Natural Sciences. He currently serves as a board member of  Stereotaxis.

Ekos

Annette Campbell-white

Ekos

J. Daniel Cole

Dan Cole serves as a General Partner of Spray Venture Partners, which he founded in 1996 and a Venture Partner of Oxford Bioscience which he joined in 2009. Dan brings twenty years of medical device operational experience and has served on the Boards of 23 med-tech companies. Prior to joining Spray, Dan served as Senior Vice President and Group President of Boston Scientific Corporation's vascular business, a $1.2 billion group including SCIMED (cardiology), Medi-tech (radiology), Meadox (vascular surgery), and EP Technologies (electrophysiology). He was also responsible for BSC's rapidly growing international operations. Dan was previously President and Chief Operating Officer of SCIMED Life Systems, a public company with revenues of $260 million in 1994 prior to the company's merger with Boston Scientific in 1995. He previously held a variety of executive and general management positions at Baxter Healthcare Divisions. He currently serves on the Board of Directors of superDimension, Pathway Medical, Tryton Medical, Direct Flow Medical, PneumRx, Conventus Orthopedics, and Thoratec Laboratories.

Ekos

Kenneth Abramowitz

Ekos

Melissa Daniels

Ms. Melissa Daniels serves as Managing Director at Morgan Stanley Expansion Capital. She also serves as a Managing Member of Morgan Stanley Venture Partners, a $1.1+B venture capital group focused on healthcare and information technology investments. Prior to joining MSVP in 2000, Ms. Daniels served as Product Manager, National Director of Fulfillment Operations, and Southeast Regional Manager within divisions of Commerce Clearing House ("CCH"). She has also served as staff to the Aviation Subcommittee of the U.S. House of Representatives and to the North Carolina Secretary of State. Ms. Daniels earned a B.A. in Economics from the University of North Carolina at Chapel Hill, and an M.B.A. from the Haas School of Business at the University of California at Berkeley. Ms. Daniels is currently a director of Clinipace Worldwide, Arcadian Management, Discoverx, EKOS, IDeaS, National Healing and Trivirix and is involved with the portfolio companies Emphasys, Solstice Neurosciences and Visiprise. She also served as Managing Director at Morgan Stanley Investment Management.

Ekos

Name

Abhijeet Lele

Annette Campbell-white

J. Daniel Cole

Kenneth Abramowitz

Melissa Daniels

Firm

Work History

Abhijeet joined Investor Growth Capital as a Managing Director in April 2009. He is based in IGC’s New York office and focuses on investments in pharmaceutical and medical device companies. Before joining IGC, Abhijeet spent 10 years as a Managing Member of EGS Healthcare Capital Partners, a venture capital firm focusing on private and public investments in biotechnology, specialty pharmaceutical and medical device companies. Prior to EGS, Abhijeet was with the New York offices of McKinsey & Co., where he primarily served medical device, pharmaceutical and health insurance clients. He previously held operating positions with Lederle Laboratories, Progenics Pharmaceuticals and Clontech Laboratories. Abhijeet received an M.B.A. from Cornell University and an M.A. from Cambridge University, where he studied Natural Sciences. He currently serves as a board member of  Stereotaxis.

Dan Cole serves as a General Partner of Spray Venture Partners, which he founded in 1996 and a Venture Partner of Oxford Bioscience which he joined in 2009. Dan brings twenty years of medical device operational experience and has served on the Boards of 23 med-tech companies. Prior to joining Spray, Dan served as Senior Vice President and Group President of Boston Scientific Corporation's vascular business, a $1.2 billion group including SCIMED (cardiology), Medi-tech (radiology), Meadox (vascular surgery), and EP Technologies (electrophysiology). He was also responsible for BSC's rapidly growing international operations. Dan was previously President and Chief Operating Officer of SCIMED Life Systems, a public company with revenues of $260 million in 1994 prior to the company's merger with Boston Scientific in 1995. He previously held a variety of executive and general management positions at Baxter Healthcare Divisions. He currently serves on the Board of Directors of superDimension, Pathway Medical, Tryton Medical, Direct Flow Medical, PneumRx, Conventus Orthopedics, and Thoratec Laboratories.

Ms. Melissa Daniels serves as Managing Director at Morgan Stanley Expansion Capital. She also serves as a Managing Member of Morgan Stanley Venture Partners, a $1.1+B venture capital group focused on healthcare and information technology investments. Prior to joining MSVP in 2000, Ms. Daniels served as Product Manager, National Director of Fulfillment Operations, and Southeast Regional Manager within divisions of Commerce Clearing House ("CCH"). She has also served as staff to the Aviation Subcommittee of the U.S. House of Representatives and to the North Carolina Secretary of State. Ms. Daniels earned a B.A. in Economics from the University of North Carolina at Chapel Hill, and an M.B.A. from the Haas School of Business at the University of California at Berkeley. Ms. Daniels is currently a director of Clinipace Worldwide, Arcadian Management, Discoverx, EKOS, IDeaS, National Healing and Trivirix and is involved with the portfolio companies Emphasys, Solstice Neurosciences and Visiprise. She also served as Managing Director at Morgan Stanley Investment Management.

Other Seats

Ekos

Ekos

Ekos

Ekos

Ekos

Ekos Management Team

5 Team Members

Ekos has 5 executives. Ekos's current Chief Executive Officer, President is Robert W Hubert.

Name

Work History

Title

Status

Robert W Hubert

Chief Executive Officer, President

Current

Douglas R Hansmann

Chief Operating Officer

Current

Thomas Keenan

Chief Executive Officer, President

Former

Peter Rule

Chief Executive Officer

Former

Anastasia Mironova

Senior Director

Former

Name

Robert W Hubert

Douglas R Hansmann

Thomas Keenan

Peter Rule

Anastasia Mironova

Work History

Title

Chief Executive Officer, President

Chief Operating Officer

Chief Executive Officer, President

Chief Executive Officer

Senior Director

Status

Current

Current

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.